Keywords: گیرنده گیرنده GLP-1; Diabète de type 2; thérapeutique; insuline; agoniste des récepteurs du GLP-1; antidiabétiques oraux; observatoire; Type 2 diabetes; therapeutics; insulin; GLP-1 receptor agonist; oral antidiabetic drugs; observatory;
مقالات ISI گیرنده گیرنده GLP-1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده گیرنده GLP-1; cardiovascular risk; diabetic kidney disease; GLP-1 receptor agonist; SGLT2 inhibitor;
Keywords: گیرنده گیرنده GLP-1; basal insulin; GLP-1 receptor agonist; type 2 diabetes mellitus; real-world;
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; pharmacodynamics; phase I; AUC24; Area under the plasma concentration time curve from 0 to 24 hours afterdose in steady state; BMI; Body mass index; CL/F; Apparent clearance; Ctrough; Trough concentration; FPG; Fasting plasma gluco
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; Lactose induction; Fusion protein; Peptide preparation; Type 2 diabetes;
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; Liraglutide; Diastolic dysfunction; Type 2 diabetes; Diabetic cardiomyopathy; Diabetic heart disease;
Keywords: گیرنده گیرنده GLP-1; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Thiazolinediones; Pioglitazone; Dipeptidyl peptidase 4 (DPP-4) inhibitors; Glucagon-like peptide-1 receptor agonists (GLP-1RA); BCAAs; branched-chain amino acids; ARB; angioten
Keywords: گیرنده گیرنده GLP-1; T2DM; type 2 diabetes; GLP-1; glucagon-like peptide-1; DPP-IV; dipeptidyl peptidase IV; des-F-sitagliptin; des-fluoro-sitagliptin; PFK; 26-phosphofructo-2-kinase/fructose-2,6-biphosphatase; CF; cytosolic fraction; DNF; nuclear fraction; qPCR; real-time PC
Keywords: گیرنده گیرنده GLP-1; Inflammation; Gliptin; GLP-1 receptor agonist; Metformin; Thiazolidinedione; Type 2 diabetes mellitus
Agonistes du récepteur du GLP-1 : puissance ou transcendance ? Des outils pour contrôler glycémie et pression artérielle
Keywords: گیرنده گیرنده GLP-1; Diabète; traitement; agoniste du récepteur du GLP-1 - HbA1c; contrôle tensionnel; risque cardiovasculaire; grandes études; critiques; biais; Diabetes; therapeutic; GLP-1 receptor agonist; HbA1c; blood pressure; cardiovascular risk; large trials; criti
Perspectives dans le traitement pharmacologique du diabète de type 2 pour les 10 prochaines années
Keywords: گیرنده گیرنده GLP-1; Antidiabétiques oraux; combinaison thérapeutique; diabète de type 2; futur; glucagon; insulinosécrétagogue; inhibiteur des SGLT2; agoniste des récepteurs du GLP-1; Antidiabetic medication; combination therapy; GLP-1 receptor agonist; glucagon; insul
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
Keywords: گیرنده گیرنده GLP-1; Glucagon-like peptide-1; Glucose metabolism; Vagus nerve; Liraglutide; Brain stem; Pancreatic β-cell proliferation; AP; Area postrema; ARC; Arcuate nucleus; AChR; Acetylcholine receptor; α-MSH; Alpha-melanocyte-stimulating hormone; BBB; Blood brain barr
GLP-1 receptor agonists and cardiovascular protection: A class effect or not?
Keywords: گیرنده گیرنده GLP-1; Class-effect; GLP-1 receptor agonist;
Battle of GLP-1 delivery technologies
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; Exenatide; Peptide delivery; Half-life; Pharmacokinetics; Fatty acid conjugate; Albumin fusion; Fc fusion;
Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials
Keywords: گیرنده گیرنده GLP-1; Diabetes Millitus; Meta-analysis; Glucagon-like peptide-1 receptors; Cardiovascular outcomes; CV; cardiovascular; CVOT; cardiovascular outcome trial; GLP-1 RA; GLP-1 receptor agonist; HbA1c; hemoglobin A1c; MI; myocardial infarction; CI; confidence interv
Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women
Keywords: گیرنده گیرنده GLP-1; Exenatide; GLP-1 receptor agonist; Polycystic ovary syndrome; Metformin; Obesity; Insulin resistance;
GLP-1 receptor agonists and heart failure in diabetes
Keywords: گیرنده گیرنده GLP-1; Congestive heart failure; Cardiac function; GLP-1 receptor agonist; LEADER; Liraglutide; Type 2 diabetes;
The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; Exenatide; Liraglutide; Heart rate; Haemodynamics; Sympathetic nervous system;
Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes
Keywords: گیرنده گیرنده GLP-1; Irisin; Type 2 diabetes; GLP-1 receptor agonist; Obesity; Myokine;
Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation
Keywords: گیرنده گیرنده GLP-1; adherence; exenatide QW; GLP-1 receptor agonist; liraglutide; persistence;
Research reportCharacterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease
Keywords: گیرنده گیرنده GLP-1; Parkinson's disease; 6-Hydroxydopamine; Dopaminergic neuron; Tyrosine hydroxylase; GLP-1 receptor agonist; Liraglutide;
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
Keywords: گیرنده گیرنده GLP-1; Tauopathy; Alzheimer’s disease; hTauP301L transgenic mouse; Phosphorylated tau; GLP-1 receptor agonist; Liraglutide
Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: A case series
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; Pancreas transplantation; Type 1 diabetes;
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation
Keywords: گیرنده گیرنده GLP-1; Type 2 diabetes; GLP-1 receptor agonist; β-Cell function; Glucagon stimulation test; C-peptide;
Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials
Keywords: گیرنده گیرنده GLP-1; Lixisenatide; Basal insulin; Basal + RAI; GLP-1 receptor agonist;
A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity
Keywords: گیرنده گیرنده GLP-1; Oxyntomodulin; Incretin; GLP-1 receptor agonist; Diabetes; Obesity; PEG;
New Incretin Hormonal Therapies in Humans Relevant to Diabetic Cats
Keywords: گیرنده گیرنده GLP-1; Cat; Feline; Diabetes mellitus; GLP-1 receptor agonist; DPP-4 inhibitor; Exenatide; Sitagliptin;
Dipeptidylpeptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) receptor agonists: Yes
Keywords: گیرنده گیرنده GLP-1; DPP-4 inhibitor; GLP-1 receptor agonist; Incretin; Sitagliptin; Exenatide; Liraglutide
PharmacotherapyOriginal researchSafety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years
Keywords: گیرنده گیرنده GLP-1; exenatide; GLP-1 receptor agonist; metformin; glucose control; HbA1c; type 2 diabetes mellitus; TZD;
Long-Term Effects of Adding Exenatide to a Regimen of Metformin and/or Sulfonylurea in Type 2 Diabetes: An Uncontrolled, Open-Label Trial in Hungary
Keywords: گیرنده گیرنده GLP-1; exenatide; GLP-1 receptor agonist; glucose control; HbA1c; hypoglycemia; type 2 diabetes mellitus;
Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferio
Keywords: گیرنده گیرنده GLP-1; diabetes mellitus; type 2; exenatide; GLP-1 receptor agonist; insulin glargine; Japanese; once weekly;
GLP-1 receptor agonists today
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; Type 2 diabetes; Liraglutide; Exenatide;
Unraveling the Science of Incretin Biology ✩
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Unraveling the Science of Incretin Biology
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus ✩
Keywords: گیرنده گیرنده GLP-1; DPP-4; exenatide-LAR; GLP-1 receptor agonist; liraglutide; sitagliptin
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use ✩
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
Keywords: گیرنده گیرنده GLP-1; GLP-1 receptor agonist; DPP-4 inhibitor; liraglutide; exenatide; sitagliptin; vildagliptin
Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Keywords: گیرنده گیرنده GLP-1; DPP-4; exenatide-LAR; GLP-1 receptor agonist; liraglutide; sitagliptin